Delivery Order SPE2DX22D0059-SPE2D825F0JYM

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,364.95 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This firm fixed price, competitively awarded contract (without set-aside designation) is scheduled for completion by September 2, 2025, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order involves the provision of pharmaceutical products and medical supplies to support federal medical procurement needs, consistent with the company's role as a critical vendor for military and veteran healthcare systems.

This award is part of AmerisourceBergen Drug Corp's extensive portfolio with the Defense Logistics Agency, which includes a prime Indefinite Delivery/Indefinite Quantity contract valued at $999,999,999 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal procurement requirements through open competition and deliver diverse medical products—from specialty medications to generic drugs and medical supplies—positions it as a key supplier within the Defense Logistics Agency's pharmaceutical procurement strategy.